Profile
AMIX ABT BSX-PA BSX SYK MDT
Company Name Autonomix Medical, Inc. Common Stock Abbott Laboratories Boston Scientific Corporation Boston Scientific Corporation Stryker Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $5.00M $223.47B $175.45B $150.72B $129.62B $107.94B
Employees 0.01K 114.00K 45.00K 53.00K 53.00K 95.00K
CEO Mr. Bradley Hauser Mr. Robert B. Ford Mr. Michael F. Mahoney Mr. Michael F. Mahoney Mr. Kevin A. Lobo Mr. Geoffrey Straub Martha
Ratings
AMIX ABT BSX-PA BSX SYK MDT
Quant Rating Score 2 4 1 3 3
Quant Rating Sell Buy Strong Sell Neutral Neutral
Trading
AMIX ABT BSX-PA BSX SYK MDT
Last Close $2.08 $128.85 $122.18 $101.9 $365.06 $84.16
High 52 $14.31 $140.22 $122.18 $106.18 $399.9 $94.5
Low 52 $0.49 $100.07 $122.18 $71.87 $315.94 $76.84
Price vs. 52 Week High -85.46 % -8.11 % 0 % -4.03 % -8.71 % -10.94 %
Price vs. 52 Week Low 324.49 % 28.76 % 0 % 41.78 % 15.55 % 9.53 %
Total Return
AMIX ABT BSX-PA BSX SYK MDT
1 Month Return 11.23 % 1.77 % 0 % -0.43 % -0.74 % -4.61 %
3 Month Return -32.69 % 3.06 % 0 % -0.04 % -7.42 % -6.69 %
6 Month Return -73.02 % 12.81 % 0 % 20.26 % 3.47 % -7.1 %
9 Month Return 61.24 % 22.43 % 0 % 36.01 % 10.07 % 6.94 %
YTD Return -44.68 % 13.92 % 0 % 14.08 % 1.39 % 5.36 %
1 Year Return -37.91 % 19.83 % 0 % 39.26 % 8.78 % 5.54 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AMIX ABT BSX-PA BSX SYK MDT
Dividend Yield Percentage (TTM) - 1.77 % - - 0.97 % 3.33 %
Dividend Paid and Capex Coverage Ration (TTM) -277.1 % 1.42 % 3.37 % 3.37 % 2.15 % 1.34 %
Dividend Per Share (TTM) - 2.28 % - - 3.28 % 2.8 %
Payout Ratio (TTM) - 28.62 % 1.24 % 1.13 % 40.73 % 84.62 %
Growth
AMIX ABT BSX-PA BSX SYK MDT
Asset Growth 987.99 % 11.2 % 12.12 % 7.66 % -1.06 %
Gross Profit Growth - 5.01 % 16.12 % 10.25 % 3.12 %
Revenue Growth - 4.59 % 17.61 % 10.23 % 3.64 %
Revenue 3 Year - -0.18 % 36.16 % 30.69 % 8.85 %
Revenue 5 Year - 34.24 % 47.52 % 49.02 % 7.41 %
Revenue 10 Year - 80.43 % 104.22 % 132.01 % 43.65 %
EBIT Growth -275.49 % 5.36 % 11.1 % -5.12 % -6.22 %
Net Income Growth -674.99 % 134.18 % 16.32 % -5.43 % -2.18 %
Net Income 3 Yeari Growth Per Share -2208.3 % 94.27 % 72.05 % 48.52 % 3.26 %
Net Income 5 Yeari Growth Per Share -2208.3 % 271.11 % -62.72 % 41.05 % -19.5 %
Net Income 10 Yeari Growth Per Share -2208.3 % 410.99 % 524.58 % 477.35 % -9.48 %
Operating Income Growth -275.49 % 5.36 % 11.1 % -5.12 % -6.22 %
Operating Cash Flow Growth (CFG) -258.5 % 17.86 % 37.24 % 14.31 % 12.39 %
Operating 3 Year CFG -34134.44 % -16.72 % 77.55 % 28.64 % 10.18 %
Operating 5 Year CFG -34134.44 % 42.4 % 76.92 % 90.05 % -1.78 %
Operating 10 Year CFG -34134.44 % 102.79 % 143.61 % 136.49 % 3.3 %
EPS Growth -14781.82 % 134.55 % 16.67 % -5.76 % -2.12 %
EPS Diluted Growth -14781.82 % 134.56 % 16.82 % -5.94 % -2.13 %
Book Value Per Share 23522.92 % 23.54 % 11.25 % 10.57 % -2.26 %
Share Holder 3 Year Equity Growth Per Share 7664.11 % 36.46 % 26.58 % 37.24 % -1.1 %
Share Holder 5 Year Equity Growth Per Share 7664.11 % 56.53 % 48.35 % 58.15 % 1.66 %
Share Holder 10 Year Equity Growth Per Share 7664.11 % 92.83 % 186.31 % 138.47 % 94.93 %
Dividend Per Share Growth - 8.02 % -100 % 6.63 % 1.54 %
Dividend 3 Year Growth Per Share - 22.8 % -100 % 26.97 % 19.02 %
Dividend 5 Year Growth Per Share - 72.53 % - 53.81 % 38.05 %
Dividend 10 Year Growth Per Share - 148.92 % - 162.12 % 147.94 %
Debt Growth - -5.37 % 13.21 % -89.16 % 6.91 %
Free Cash Flow Growth -259.52 % 25.54 % 55.31 % 11.19 % 13.54 %
Updated On 31 Mar 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024 26 Apr 2024
Profitability
AMIX ABT BSX-PA BSX SYK MDT
Gross Profit Margin TTM - 55.59 % 67.02 % 67.15 % 62.84 % 62.89 %
Return on Assets TTM -114.01 % 16.46 % 4.7 % 5.16 % 6.97 % 4.73 %
Return on Equity TTM -212.47 % 32.37 % 8.94 % 9.82 % 15.02 % 8.69 %
Return on Capital Employed TTM -110.77 % 10.32 % 8.63 % 9.32 % 10.75 % 7.74 %
Net Income Per EBT TTM 100 % 191.1 % 81.07 % 81.97 % 85.71 % 81.56 %
EBT Per Ebit TTM 126.73 % 101.01 % 80.13 % 80.59 % 91.89 % 86.39 %
EBIT Per Revenue TTM - 16.55 % 17.01 % 17.52 % 16.82 % 18.21 %
Cash Flow To Debt Ratio TTM -709.89 % 56.97 % 30.82 % 30.82 % 31.2 % 27.41 %
Receivables Turnover TTM - 4.42 6.55 6.86 5.67 5.43
Payables Turnover TTM 0.38 4.44 5.75 6.01 5 5.39
Inventory Turnover TTM - 3.01 1.97 2.05 1.76 2.2
Fixed Asset Turnover TTM - 393.6 % 447.28 % 468.83 % 655.31 % 503.55 %
Asset Turnover TTM - 51.53 % 42.51 % 44.56 % 52.58 % 36.9 %
Operating Cash Flow Per Share TTM -4.34 4.94 2.33 2.33 11.13 5.69
Free Cash Flow Per Share TTM -4.35 3.67 1.66 1.65 9.15 4.26
Cash Per Share TTM 638.42 % 460.07 % 28.12 % 28.03 % 1155.38 % 617.75 %
Operating Cash Flow Sales Ratio TTM - 20.4 % 20.51 % 19.57 % 18.77 % 21.97 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.36 % 74.21 % 70.98 % 70.98 % 82.2 % 74.96 %
Cash Flow Coverage Ratios TTM -709.89 % 56.97 % 30.82 % 30.82 % 31.2 % 27.41 %
Price To Free Cash Flows Ratio TTM -0.62 35.19 57.79 61.82 37.17 19.74
Price To Operating Cash Flows Ratio TTM -0.47 26.07 40.82 43.82 30.5 14.8
Price Cash Flow Ratio TTM -0.47 26.07 40.82 43.82 30.5 14.8
Income Statement (TTM)
AMIX ABT BSX-PA BSX SYK MDT
Revenue $0B $41.95B $16.75B $16.75B $22.6B $32.36B
Gross Profit $-0B $23.24B $11.49B $11.49B $14.44B $21.15B
Gross Profit Ratio 0% 55.41% 68.61% 68.61% 63.91% 65.34%
EBITDA $-0.02B $10.83B $2.6B $2.6B $5.72B $8.2B
Net Income $-0.02B $13.4B $1.85B $1.85B $2.99B $3.68B
EPS Diluted -21.09 7.64 1.25 1.25 7.76 2.76
Balance Sheet (MRQ)
AMIX ABT BSX-PA BSX SYK MDT
Long Term Debt $0B $13.52B $8.97B $8.97B $0B $24.77B
Total Liabilities $0B $33.51B $17.39B $17.39B $22.34B $39.56B
Total Equity $0.01B $47.9B $22B $22B $20.63B $50.42B
Total Investments $0B $1.24B $0.56B $0.56B $0.75B $8.34B
Total Debt $0B $15.02B $10.75B $10.75B $1.41B $26.05B
Total Assets $0.01B $81.41B $39.4B $39.4B $42.97B $89.98B
Cash Flow Statement (TTM)
AMIX ABT BSX-PA BSX SYK MDT
Net Income $-0.02B $13.4B $1.85B $1.85B $2.99B $3.68B
Inventory $0B $-0.06B $-0.23B $-0.23B $0.05B $-0.14B
Dividends Paid $0B $-3.84B $0B $0B $-1.22B $-3.67B
Operating Cash Flow $-0.01B $8.56B $3.44B $3.44B $4.24B $6.79B
Capital Expenditure $-0B $-2.21B $-0.79B $-0.79B $-0.76B $-1.59B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 128.85
ADGM Adagio Medical Holdings, Inc. 1.3
AEMD Aethlon Medical, Inc. 0.3813
AFIB Acutus Medical, Inc. 0.041
AHCO AdaptHealth Corp. 8.41
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 183.35
ALUR Allurion Technologies Inc. 2.4
ANIK Anika Therapeutics, Inc. 14.43
AORT Artivion, Inc. 23.84
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 0.8905
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 11.51
AVNS Avanos Medical, Inc. 12.35
AVR Anteris Technologies Global Corp. Common Stock 4.98
AXDX Accelerate Diagnostics, Inc. 0.5775
AXGN AxoGen, Inc. 16.4
AXNX Axonics, Inc. 70.98
ETFs With Exposure to AMIX
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0 170
IWC iShares Micro-Cap ETF 0.00039 110.33
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 128.99
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 129
VEMPX Vanguard Extended Market Index InstlPlus 0 318.32
Unlock